Next, we evaluated the specific promoter methylation of the four genes from the TGFβ signaling pathway (TGFBR2, SMAD4, SMAD7 and SNAI1) evaluated in SNU449 cells in resected human HCC tumors, as well as in the surrounding non-tumor tissues. The gene discussed is TGFBR2; the disease is neoplasm.